Items where authors include "Radhakrishna, G."

Article

Mukherjee, S., Qi, C., Shaw, R. et al. (20 more authors) (2024) Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial. European Journal of Cancer, 209. 114236. ISSN 0959-8049

Mortensen, H.R., Populaire, P., Hoffmann, L. et al. (33 more authors) (2024) Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer. Radiotherapy and Oncology, 190. 109980. ISSN 0167-8140

Chuter, R., Glassborow, E., Speight, R. et al. (9 more authors) (2022) A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence. Physics and Imaging in Radiation Oncology, 21. pp. 78-83. ISSN 2405-6316

Slevin, F. orcid.org/0000-0002-7176-904X, Beasley, M., Speight, R. et al. (5 more authors) (2020) Evaluation of clinician contouring for pancreatic stereotactic ablative radiotherapy (SABR) during an RCR contouring workshop. Clinical Oncology, 32 (Supplement 1). E3. ISSN 0936-6555

Proceedings Paper

Mukherjee, S., Hurt, C., Cox, C. et al. (17 more authors) (2020) Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the randomized phase II neoscope trial. In: Journal of Clinical Oncology. 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, CA, USA. American Society of Clinical Oncology , p. 373.